Sequence analysis and expression of the cDNA for the phenol-sulfating form of human liver phenol sulfotransferase. 1993

T W Wilborn, and K A Comer, and T P Dooley, and I M Reardon, and R L Heinrikson, and C N Falany
Department of Pharmacology, University of Alabama, Birmingham 35294.

A cDNA encoding the human liver phenol-sulfating form of phenol sulfotransferase (P-PST) has been isolated and characterized from a lambda Uni-Zap XR human liver cDNA library. P-PST is the major form of phenol sulfotransferase involved in drug and xenobiotic metabolism in human liver. P-PST is also responsible for the sulfation and activation of minoxidil to its therapeutically active sulfate ester. The full length cDNA, P-PST-1, is 1206 base pairs in length and encodes a 295-amino acid protein with a molecular mass of 34,097 Da. The translation sequence of P-PST-1 is 96% similar to the amino acid sequences of five peptides derived from the purified protein. In vitro transcription and translation of P-PST-1 generated a protein that comigrates with immunoreactive P-PST from human liver. Significant increases in sulfotransferase activity toward two P-PST-specific substrates, minoxidil and 4-nitrophenol, were detected in cytosol prepared from COS-7 cells transfected with P-PST-1 in the expression vector p-SV-SPORT-1. Northern blot analysis of human liver RNA detected a transcript of approximately 1300 nucleotides in length. Characterization of P-PST at the molecular level provides insight into the structure and heterogeneity of this major class of drug-metabolizing enzymes.

UI MeSH Term Description Entries
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D004247 DNA A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine). DNA, Double-Stranded,Deoxyribonucleic Acid,ds-DNA,DNA, Double Stranded,Double-Stranded DNA,ds DNA
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D001483 Base Sequence The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence. DNA Sequence,Nucleotide Sequence,RNA Sequence,DNA Sequences,Base Sequences,Nucleotide Sequences,RNA Sequences,Sequence, Base,Sequence, DNA,Sequence, Nucleotide,Sequence, RNA,Sequences, Base,Sequences, DNA,Sequences, Nucleotide,Sequences, RNA
D014158 Transcription, Genetic The biosynthesis of RNA carried out on a template of DNA. The biosynthesis of DNA from an RNA template is called REVERSE TRANSCRIPTION. Genetic Transcription
D014176 Protein Biosynthesis The biosynthesis of PEPTIDES and PROTEINS on RIBOSOMES, directed by MESSENGER RNA, via TRANSFER RNA that is charged with standard proteinogenic AMINO ACIDS. Genetic Translation,Peptide Biosynthesis, Ribosomal,Protein Translation,Translation, Genetic,Protein Biosynthesis, Ribosomal,Protein Synthesis, Ribosomal,Ribosomal Peptide Biosynthesis,mRNA Translation,Biosynthesis, Protein,Biosynthesis, Ribosomal Peptide,Biosynthesis, Ribosomal Protein,Genetic Translations,Ribosomal Protein Biosynthesis,Ribosomal Protein Synthesis,Synthesis, Ribosomal Protein,Translation, Protein,Translation, mRNA,mRNA Translations
D015239 Arylsulfotransferase A sulfotransferase that catalyzes the sulfation of a phenol in the presence of 3'-phosphoadenylylsulfate as sulfate donor to yield an aryl sulfate and adenosine 3',5'-bisphosphate. A number of aromatic compounds can act as acceptors; however, organic hydroxylamines are not substrates. Sulfate conjugation by this enzyme is a major pathway for the biotransformation of phenolic and catechol drugs as well as neurotransmitters. EC 2.8.2.1. Phenol Sulfotransferase,Acetaminophen Sulphotransferase,Aryl Sulfotransferase,Catecholamine Sulfotransferase A,Catecholamine Sulfotransferase B,Dopamine Sulfotransferase,Flavonoid Sulfotransferase,Phenol Sulfokinase,Phenol Sulfotransferase M,Phenol Sulfotransferase P,Phenolsulfokinase,Phenolsulfotransferase P,Sulfokinase,Sulfotransferase A, Catecholamine,Sulfotransferase B, Catecholamine,Sulfotransferase M, Phenol,Sulfotransferase P, Phenol,Sulfotransferase, Aryl,Sulfotransferase, Dopamine,Sulfotransferase, Flavonoid,Sulfotransferase, Phenol,Sulphotransferase, Acetaminophen

Related Publications

T W Wilborn, and K A Comer, and T P Dooley, and I M Reardon, and R L Heinrikson, and C N Falany
May 1990, Archives of biochemistry and biophysics,
T W Wilborn, and K A Comer, and T P Dooley, and I M Reardon, and R L Heinrikson, and C N Falany
October 1997, Protein expression and purification,
T W Wilborn, and K A Comer, and T P Dooley, and I M Reardon, and R L Heinrikson, and C N Falany
September 1995, Drug metabolism and disposition: the biological fate of chemicals,
T W Wilborn, and K A Comer, and T P Dooley, and I M Reardon, and R L Heinrikson, and C N Falany
September 1986, Archives of biochemistry and biophysics,
T W Wilborn, and K A Comer, and T P Dooley, and I M Reardon, and R L Heinrikson, and C N Falany
February 1994, Biochemical and biophysical research communications,
T W Wilborn, and K A Comer, and T P Dooley, and I M Reardon, and R L Heinrikson, and C N Falany
August 1988, Molecular pharmacology,
T W Wilborn, and K A Comer, and T P Dooley, and I M Reardon, and R L Heinrikson, and C N Falany
December 1994, Biochemical and biophysical research communications,
T W Wilborn, and K A Comer, and T P Dooley, and I M Reardon, and R L Heinrikson, and C N Falany
May 1985, Biochemistry,
T W Wilborn, and K A Comer, and T P Dooley, and I M Reardon, and R L Heinrikson, and C N Falany
February 1998, Molecular pharmacology,
T W Wilborn, and K A Comer, and T P Dooley, and I M Reardon, and R L Heinrikson, and C N Falany
August 1992, Molecular pharmacology,
Copied contents to your clipboard!